Inflation Rate Projected to Reach 6 in Second Quarter Top Economic Forecasters Say Bloom Energy Partners with Nebius in 26 Billion Deal for AI Data Center Power Shares Rise 12 Telecoms CEO Warns Europe Underestimates Risks of US Dominance in Satellites and AI AI Drug Discovery Poised to Accelerate Treatments for Brain Conditions Like MND Paul Tudor Jones No Chance Warsh Can Push Fed to Cut Rates Ajmera Realty Shares Surge 96 on Strong FY26 Financial Results NNVC Q1 2026 Earnings NarrowerthanExpected Loss Surprises but Stock Dips JOYY Q4 2025 Earnings EPS Misses Estimates Amid Widening Losses Shares Slip Viavi Solutions VIAV Q1 2026 Earnings EPS Surges Past Estimates as Shares Rise Riley Exploration Permian Inc REPX Q1 2026 Earnings Deep EPS Miss Amid Strong Stock Rally OCS Q1 2026 Earnings EPS Misses Estimates as Biotech Firm Continues RD Investments MLI Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Robust Demand BILL Holdings Stock Slips as Market Weighs Growth Prospects Key Levels to Watch Clough Global Dividend and Income Fund GLV Edges Higher as Price Tests Key Resistance SR Bancorp Inc SRBK Holds Steady Near Support as Trading Volume Remains Modest ClearThink 1 Acquisition Corp Units CTAAU Hold Steady at 1006 Stability in a Quiet SPAC Market Artius II Acquisition Rights AACBR Hold Steady at 025 as Traders Watch Key Levels KRRO Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Stock Reaction PARR Q1 2026 Earnings EPS Misses Estimates Stock Declines WATT Q1 2026 Earnings EPS Surprise of 3464 Despite No Revenue Stock Declines Xenetic Biosciences Q2 2025 Earnings Narrowed Loss Beats Estimates as Pipeline Advances WidePoint WYY Q1 2026 Earnings EPS Surprises Positively Revenue Not Disclosed Stock Declines 19 HEI Q4 2025 Earnings EPS Surprise Beats Estimates Despite Tepid Market Response Cancer Treatment Costs Already Hundreds of Thousands Could Rise Further Affordable Care Act Lessons from a Survivor LYEL Q1 2026 Earnings Significant EPS Beat Driven by Operational Efficiency and Pipeline Progress KalVista Pharmaceuticals KALV Holds Steady Near Support After Modest Gain